BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23551745)

  • 1. Assessing the use of haemostatic sealants in tubeless percutaneous renal access and their effect on renal drainage and histology: an experimental porcine study.
    Rigopoulos C; Kyriazis I; Kallidonis P; Kalogeropoulou C; Koumoundourou D; Georgiopoulos I; Petsas T; Karnabatidis D; Constantinides C; Liatsikos E
    BJU Int; 2013 Jul; 112(2):E114-21. PubMed ID: 23551745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrin sealant enables tubeless percutaneous stone surgery.
    Noller MW; Baughman SM; Morey AF; Auge BK
    J Urol; 2004 Jul; 172(1):166-9. PubMed ID: 15201763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tubeless percutaneous nephrolithotomy: a prospective feasibility study and review of previous reports.
    Shah HN; Kausik VB; Hegde SS; Shah JN; Bansal MB
    BJU Int; 2005 Oct; 96(6):879-83. PubMed ID: 16153222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin treatment and tract closure for tubeless percutaneous nephrolithotomy: University of California, Irvine, technique.
    Kaufmann OG; Sountoulides P; Kaplan A; Louie M; McDougall E; Clayman R
    J Endourol; 2009 Oct; 23(10):1739-41. PubMed ID: 19785557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gelatin packing of intracortical tract after percutaneous nephrostomy lithotripsy for decreasing bleeding and urine leakage.
    Yu DS
    J Chin Med Assoc; 2006 Apr; 69(4):162-5. PubMed ID: 16689197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Closing the tract of mini-percutaneous nephrolithotomy with gelatine matrix hemostatic sealant can replace nephrostomy tube placement.
    Nagele U; Schilling D; Anastasiadis AG; Corvin S; Seibold J; Kuczyk M; Stenzl A; Sievert KD
    Urology; 2006 Sep; 68(3):489-93; discussion 493-4. PubMed ID: 16979734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of absorbable gelatin sponge as an adjunct to "totally tubeless percutaneous nephrolithotomy".
    Singh P; Mandhani A
    Arch Esp Urol; 2009 Jul; 62(6):423-9. PubMed ID: 19736373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathologic evaluation of hemostatic agents in percutaneous nephrolithotomy tracts in a porcine model.
    Lipkin ME; Mancini JG; Simmons WN; Raymundo ME; Yong DZ; Wang AJ; Ferrandino MN; Albala DM; Preminger GM
    J Endourol; 2011 Aug; 25(8):1353-7. PubMed ID: 21740197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective, randomized trial evaluating the safety and efficacy of fibrin sealant in tubeless percutaneous nephrolithotomy.
    Shah HN; Hegde S; Shah JN; Mohile PD; Yuvaraja TB; Bansal MB
    J Urol; 2006 Dec; 176(6 Pt 1):2488-92; discussion 2492-3. PubMed ID: 17085137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemostatic flowables & sealants.
    Waddington C
    ORL Head Neck Nurs; 2012; 30(3):18-9. PubMed ID: 23311114
    [No Abstract]   [Full Text] [Related]  

  • 11. TachoSil(®) sealed tubeless percutaneous nephrolithotomy to reduce urine leakage and bleeding: outcome of a randomized controlled study.
    Cormio L; Perrone A; Di Fino G; Ruocco N; De Siati M; de la Rosette J; Carrieri G
    J Urol; 2012 Jul; 188(1):145-50. PubMed ID: 22591964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sealing percutaneous nephrolithotomy tracts with gelatin matrix hemostatic sealant: initial clinical use.
    Lee DI; Uribe C; Eichel L; Khonsari S; Basillote J; Park HK; Li CC; McDougall EM; Clayman RV
    J Urol; 2004 Feb; 171(2 Pt 1):575-8. PubMed ID: 14713762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of a gelatine-thrombin matrix for closure of the access tract without a nephrostomy tube in minimally invasive percutaneous nephrolitholapaxy].
    Schilling D; Winter B; Merseburger AS; Anastasiadis AG; Walcher U; Stenzl A; Nagele U
    Urologe A; 2008 May; 47(5):601-7. PubMed ID: 18311555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sealing of percutaneous nephrolithotomy access after complete stone removal with a hemostyptic gelatin powder (Spongostan)].
    Schick V
    Aktuelle Urol; 2006 Jan; 37(1):52-7. PubMed ID: 16440247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The management of the access tract after percutaneous nephrolithotomy.
    Hüsch T; Reiter M; Mager R; Steiner E; Herrmann TR; Haferkamp A; Schilling D
    World J Urol; 2015 Dec; 33(12):1921-8. PubMed ID: 25903804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Questioning the wisdom of tubeless percutaneous nephrolithotomy (PCNL): a prospective randomized controlled study of early tube removal vs tubeless PCNL.
    Mishra S; Sabnis RB; Kurien A; Ganpule A; Muthu V; Desai M
    BJU Int; 2010 Oct; 106(7):1045-8; discussion 1048-9. PubMed ID: 20151965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of TachoSil as haemostatic treatment versus standard suturing in kidney tumour resection: a randomised prospective study.
    Siemer S; Lahme S; Altziebler S; Machtens S; Strohmaier W; Wechsel HW; Goebell P; Schmeller N; Oberneder R; Stolzenburg JU; Becker H; Lüftenegger W; Tetens V; Van Poppel H
    Eur Urol; 2007 Oct; 52(4):1156-63. PubMed ID: 17467884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal parenchymal injury after standard and mini percutaneous nephrostolithotomy.
    Traxer O; Smith TG; Pearle MS; Corwin TS; Saboorian H; Cadeddu JA
    J Urol; 2001 May; 165(5):1693-5. PubMed ID: 11342957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tubeless PCNL].
    Saussine C; Lechevallier E; Traxer O
    Prog Urol; 2008 Dec; 18(12):901-7. PubMed ID: 19033051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of nephrostomy drainage types following percutaneous nephrolithotomy requiring multiple tracts: single tube versus multiple tubes versus tubeless.
    Resorlu B; Kara C; Sahin E; Unsal A
    Urol Int; 2011; 87(1):23-7. PubMed ID: 21720147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.